Open-But-Unused SUD Reprocessing Will Not Be Pursued - FDA's Kessler
This article was originally published in The Gray Sheet
Executive Summary
FDA expects to issue a final guidance by August on its approach to regulate reprocessing of single-use devices (SUDs) by third-party facilities, according to Larry Kessler, director of the Center for Devices and Radiological Health's Office of Surveillance and Biometrics.
You may also be interested in...
OEMs, FDA Still At Odds Over Premarket Requirements For Reprocessed SUDs
It appears unlikely that FDA will require all reprocessor submissions for single-use devices to support a "reusable" claim, despite opposing comments by Smith & Nephew and other original equipment manufacturers.
OEMs, FDA Still At Odds Over Premarket Requirements For Reprocessed SUDs
It appears unlikely that FDA will require all reprocessor submissions for single-use devices to support a "reusable" claim, despite opposing comments by Smith & Nephew and other original equipment manufacturers.
Reprocessors, OEMs Will Operate On "Level Playing Field," Feigal Testifies
FDA Center for Devices and Radiological Health Director David Feigal promised the House Commerce/ Oversight and Investigations Subcommittee Feb. 10 that new regulations on reuse of single-use devices will be equally applied to manufacturers and reprocessors.